Follow
BinySky
BinySky
Pasien of Kontes Seo
No verified email - Homepage
Title
Cited by
Cited by
Year
Cell-surface CD74 initiates a signaling cascade leading to cell proliferation and survival
D Starlets, Y Gore, I Binsky, M Haran, N Harpaz, L Shvidel, ...
Blood 107 (12), 4807-4816, 2006
3522006
IL-8 secreted in a macrophage migration-inhibitory factor-and CD74-dependent manner regulates B cell chronic lymphocytic leukemia survival
I Binsky, M Haran, D Starlets, Y Gore, F Lantner, N Harpaz, L Leng, ...
Proceedings of the National Academy of Sciences 104 (33), 13408-13413, 2007
2242007
Circulating B-cell chronic lymphocytic leukemia cells display impaired migration to lymph nodes and bone marrow
TN Hartmann, V Grabovsky, W Wang, P Desch, G Rubenzer, S Wollner, ...
Cancer research 69 (7), 3121-3130, 2009
1012009
TAp63 regulates VLA-4 expression and chronic lymphocytic leukemia cell migration to the bone marrow in a CD74-dependent manner
I Binsky, F Lantner, V Grabovsky, N Harpaz, L Shvidel, A Berrebi, ...
The Journal of Immunology 184 (9), 4761-4769, 2010
792010
Method and system for label table caching in a routing device
M Foster, M Dorsett
US Patent App. 10/066,014, 2002
13*2002
Compositions comprising soluble CD84 or anti-CD84 antibodies and methods for diagnosing and treating B-CLL
I Shachar, I Binsky, M Sobotta
US Patent 9,109,029, 2015
42015
Compositions comprising soluble CD84 or anti-CD84 antibodies and methods for diagnosing and treating B-CLL
I Shachar, I Binsky, M Sobotta
US Patent 8,686,121, 2014
42014
A Phase I, Dose Escalation Study of Lapatinib in Combination with Carboplatin, Paclitaxel, with or without Trastuzumab in Patients with Metastatic Breast Cancer: An Update.
A Storniolo, G Magrinat, P Rubin, B Parker, A Rush-Taylor, V Sheidler, ...
Cancer Research 69 (24_Supplement), 3097-3097, 2009
42009
Anti CD84 antibodies, compositions comprising same and uses thereof
I Shachar, I Binsky, A Marom
US Patent 10,611,839, 2020
22020
Compositions comprising soluble cd84 or anti-cd84 antibodies and methods for diagnosing and treating b-cll
I Shachar, I Binsky, M Sobotta
US Patent App. 16/430,512, 2019
12019
Compositions comprising soluble CD84 or anti-CD84 antibodies and methods for diagnosing and treating B-CLL
I Shachar, I Binsky, M Sobotta
US Patent 10,329,347, 2019
2019
CD74, the Natural Receptor for MIF, Regulates Cell Survival in Health and Disease
A Marom, S Becker-Herman
The MIF Handbook, 55, 2012
2012
Circulating B-cell chronic lymphocytic leukemia cells display impaired migration to lymph nodes due to reduced LFA-1 expression
TN Hartmann, V Grabovsky, W Wang, P Desch, S Wollner, I Binsky, ...
Blood, The Journal of the American Society of Hematology 112 (11), 3135-3135, 2008
2008
CD74 Is a Novel Survival Receptor in Chronic Lymphocytic Leukemia
MZH Haran, I Binsky, D Starlets, N Harpaz, L Shvidel, A Berrebi, I Shachar
Haematologica-The Hematology Journal 92 (suppl 1), 196-196, 2007
2007
CD74 Is a Novel Survival Receptor in Chronic Lymphocytic Leukemia.
I Binsky, M Haran, D Starlets, N Harpaz, L Shvidel, A Berrebi, I Shachar
Blood, The Journal of the American Society of Hematology 108 (11), 2812-2812, 2006
2006
Cell surface CD74 initiates a signaling cascade leading to cell proliferation
A Berrebi, I Shachar, D Starlets, Y Gore, I Binsky, M Haran, N Harpaz, ...
The system can't perform the operation now. Try again later.
Articles 1–16